StockData
Teva Pharmaceutical Industries Ltd logo

Teva Pharmaceutical Industries Ltd

TEVANYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 7/30127% above fair value
$42.23−0.39 (-0.92%)

Close on Nov 18, 2026Market cap $49.21BP/E 70.4Yield –

Teva Pharmaceutical Industries Teva API (TAPI) Reporting Unit by Quarter

Teva API (TAPI) Reporting Unit — Goodwill Carrying Balance ($M)

Teva Pharmaceutical Industries Teva API (TAPI) Reporting Unit: $0M in Q4 2025. That is the lowest of the 15 quarters on record here.

Latest, Q4 2025
0
Period ended Dec 31, 2025
Change on a year earlier
–
0 in Q4 2024
History
15 quarters
Since Q4 2021
Sources
12
Documents cited below

Where the Q4 2025 figure comes from

Source: SEC Form 10-K (0001193125-26-034532) ↗

Reported in SEC Form 10-K / Form 10-Q (XBRL & Footnotes).

quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedTeva API (TAPI) Reporting Unit — Goodwill Carrying Balance ($M)Year on yearSource
Q4 2025Dec 31, 20250–SEC Form 10-K (0001193125-26-034532) ↗
Q3 2025Sep 30, 20250-100.0%SEC Form 10-Q (0001193125-25-266895) ↗
Q2 2025Jun 30, 20250-100.0%SEC Form 10-Q (0001193125-25-169296) ↗
Q1 2025Mar 31, 20250-100.0%SEC Form 10-Q (0001193125-25-114889) ↗
Q4 2024Dec 31, 20240-100.0%SEC Form 10-K (0001193125-26-034532) ↗
Q3 2024Sep 30, 2024318-75.3%SEC Form 10-Q (0001193125-24-252039) ↗
Q2 2024Jun 30, 2024895-31.3%SEC Form 10-Q (0001193125-24-189924) ↗
Q1 2024Mar 31, 20241,299-0.5%SEC Form 10-Q (0001193125-24-134200) ↗
Q4 2023Dec 31, 20231,3130.0%SEC Form 10-K (0001193125-26-034532) ↗
Q3 2023Sep 30, 20231,288–SEC Form 10-Q (0001193125-23-274495) ↗
Q2 2023Jun 30, 20231,303+389.8%SEC Form 10-Q (0001193125-23-201707) ↗
Q1 2023Mar 31, 20231,305–SEC Form 10-Q (0001193125-23-140697) ↗
Q4 2022Dec 31, 20221,313+1.5%SEC Form 10-K (0001193125-26-034532) ↗
Q2 2022Jun 30, 2022266–SEC Form 10-K (0001193125-23-031250) ↗
Q4 2021Dec 31, 20211,293–SEC Form 10-K (0001193125-25-020826) ↗

Cite this data

StockData. (2026). Teva Pharmaceutical Industries Teva API (TAPI) Reporting Unit ($M), quarterly Q4 2021–Q4 2025 [Data set]. Compiled from Teva Pharmaceutical Industries SEC filings and investor materials. https://stockdatahq.com/stocks/teva/kpis/sub-tapi-goodwill

See every metric in the Teva Pharmaceutical Industries KPI table. Data updated Nov 10, 2026.

See a number that looks wrong?